The human touch in tech-enabled trials
Today's clinical trial landscape helps speed-to-market therapies that promise better outcomes for cancer patients, but the path to reach and treat these individuals isn't always the clearest. By implementing patient services and supports, the trial participant becomes an active partner in the trial, not a patient living within the trial.
Learn how IQVIA decentralized trial approaches help oncology programs improve trials by better understanding the patient needs to reduce patient burden and extend the four walls of the study site.
The human touch in tech-enabled trials
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.